Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Pharmacist James Quinn faces charges in counterfeit drugs trial

by News team

Suspended pharmacist James Quinn, aged 69, of Virginia Water, Surrey, is one of five men alleged to have been knowingly involved in the importation and distribution of counterfeit medicines in the UK.

In a trial that got under way at Croydon Crown Court this week, prosecutor Andrew Marshall said that the case is considered to represent the most serious breach of the medicines control regime within the EU.

Discovery of the fake batches of Plavix (clopidogrel), Zyprexa (olanzapine) and Casodex (bicalutamide) in 2007 led to class I medicines recalls (PJ, 2 June 2007, p635 and 9 June 2007, p661). It was the first known incidence of counterfeit medicines reaching the UK supply chain through parallel imports.

The men are accused of conspiring together and with others to defraud pharmaceutical wholesalers, pharmacists, members of the public and holders of intellectual property rights in pharmaceuticals between 1 January 2006 and 30 June 2007.

All five men are also accused of selling or supplying Casodex and Plavix without a marketing authorisation and of selling or distributing counterfeit Casodex and Plavix.

Four of them (not including Mr Quinn) are accused of selling or supplying Zyprexa without a marketing authorisation and of selling or distributing counterfeit Zyprexa.

The case has been brought following an investigation by the Medicines and Healthcare products Regulatory Agency. The alleged conspiracy involved bringing counterfeit medicines from China to Belgium via Singapore.

The prosecution’s case is that the products were then brought to Britain under the pretence that they were parallel imports, supplied by appropriately licensed people and had originated in France. Two of the defendants held wholesale dealer’s licences.

All five defendants deny the charges. The trial is not expected to be concluded until March 2011.

Citation: The Pharmaceutical Journal URI: 11050780

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £38.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £38.00Buy now
  • Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons

    Clarke's Analysis of Drugs and Poisons is the definitive reference source of analytical data for drugs and poisons.

    £535.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Chinese money and tablets (Amabrao/Dreamstime

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.